吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 | 55115-79-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 中文名称: 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮
• 英文名称: Pyrido<3',2':4,5>thieno<3,2-d>pyrimidin-4(1H)-one
• 英文别名: 3H-pyrido[3',2';4,5]thieno[3,2-d]pyrimid-4-one；pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one；Pyrido<3',2'-4,5>thieno<3,2-d>pyrimid-4-on；3H-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-one；8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,10,12-pentaen-6-one
• CAS: 55115-79-2
• 化学式: C₉H₅N₃OS
• mdl: MFCD01312791
• 分子量: 203.224
• InChiKey: XVEUJPQIDXXNFD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  82.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 在 palladium on activated charcoal 氢气 、 一水合肼 、 三氯氧磷 作用下， 以 吡啶 、 乙醇 为溶剂， 反应 2.0h， 生成 pyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine
  参考文献：
  名称：

  吡啶并[3'，2'：4,5]噻吩并[3,2- d ]嘧啶衍生物的合成†

  摘要：

  吡啶并[3'，2'：4,5] thieno [3,2- d ]嘧啶及其衍生物已被合成。

  DOI：

  10.1002/jhet.5570110622
• 作为产物：
  描述：

  2-氯-3-氰基吡啶 在 sodium hydride 作用下， 以 二甲基亚砜 为溶剂， 反应 8.0h， 生成 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮
  参考文献：
  名称：

  酪氨酸激酶抑制剂。16.作为表皮生长因子受体酪氨酸激酶的有效抑制剂的6,5,6-三环苯并噻吩并[3,2-d]嘧啶和嘧啶并[5,4-b-]和-[4,5-b]吲哚。

  摘要：

  据报道，基本的苯胺基嘧啶药效基团的几种精制方法是表皮生长因子受体（EGFr）酪氨酸激酶的有效和选择性抑制剂。本文报道了一系列抑制剂，其中一些6,5-双环杂芳族系统通过其C-2和C-3位置与该苯胺嘧啶药效团融合。尽管产生的三轮车并未产生某些（5/6），6,6-双环系统的巨大效能，但最好的三轮车的EGFr TK的IC（50）约为1 nM。对吲哚并嘧啶中4-位侧链的研究证实，间溴苯胺是效力的最佳取代基。

  DOI：

  10.1021/jm9903949

文献信息

• mGluR1 antagonists as therapeutic agents
  申请人：Matasi J. Julius

  公开号：US20060009477A1

  公开（公告）日：2006-01-12

  In its many embodiments, the present invention provides tricyclic compounds of formula I (wherein J 1 -J 4 , X, and R 1 —R 5 are as defined herein) useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds and compositions to treat diseases associated with metabotropic glutamate receptor (e.g., mGluR1) such as, for example, pain, migraine, anxiety, urinary incontinence and neurodegenerative diseases such Alzheimer's disease.

  在其多种实施方式中，本发明提供了式I的三环化合物（其中J1-J4、X和R1—R5如本文所定义）作为代谢型谷氨酸受体（mGluR）拮抗剂，特别是作为选择性代谢型谷氨酸受体1拮抗剂，含有该化合物的药物组合物，以及使用该化合物和组合物治疗与代谢型谷氨酸受体（例如mGluR1）相关的疾病的方法，例如疼痛、偏头痛、焦虑、尿失禁和阿尔茨海默病等神经退行性疾病。
• [EN] GLUCOSE UPTAKE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DU PRÉLÈVEMENT DU GLUCOSE ET LEURS UTILISATIONS
  申请人：METABOMED LTD

  公开号：WO2021095032A1

  公开（公告）日：2021-05-20

  The present invention relates to novel compounds that modulate cellular glucose uptake by affecting various targets, including, but not limited to those related to glycolysis and known transporters/co-transporters of the GLUT family. The compounds according to the invention are useful for treating cancer such as: neuroendrocrine neoplasms, gastrointestinal stromal tumors (GIST), renal cell carcinoma, paraganglioma, pheochromocytoma, pituitary adenoma, colorectal cancer, lung cancer, gastric cancer, pancreatic cancer sarcoma, head and neck cancer, melanoma, ovarian cancer and other cancers that rely on high levels of glycolysis for survival and proliferation; as well as in treating of autoimmune diseases, inflammation, infectious diseases, and metabolic diseases.

  本发明涉及一种新型化合物，通过影响各种靶标，包括但不限于与糖酵解和GLUT家族的已知转运体/共转运体相关的靶标，来调节细胞葡萄糖摄取。根据本发明的化合物可用于治疗癌症，如：神经内分泌肿瘤、胃肠道间质瘤（GIST）、肾细胞癌、副神经节瘤、嗜铬细胞瘤、垂体腺瘤、结直肠癌、肺癌、胃癌、胰腺癌、肉瘤、头颈癌、黑色素瘤、卵巢癌以及其他依赖高水平糖酵解进行生存和增殖的癌症；以及用于治疗自身免疫疾病、炎症、传染病和代谢性疾病。
• Protein Kinase Inhibitors
  申请人：Hurley H. Laurence

  公开号：US20080051414A1

  公开（公告）日：2008-02-28

  Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R 1 , R 2 , R 3 , X, Z, L 1 , Cycl 1 , L 2 and Cycl 2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.

  本发明揭示了具有在治疗蛋白激酶介导的疾病和病状（如癌症）中的用途的蛋白激酶抑制剂。本发明的化合物具有以下结构：包括立体异构体、前药和其药学上可接受的盐，其中A是从以下环基中选择的环基：并且其中R1、R2、R3、X、Z、L1、Cycl1、L2和Cycl2的定义如本文所述。本发明还揭示了包含本发明化合物的组合物，以及与其使用相关的方法。
• PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR
  申请人：Christensen Ulf Bech

  公开号：US20100121056A1

  公开（公告）日：2010-05-13

  The present invention relates to intercalator pseudonucleotides. Intercalator pseudonucleotides according to the invention are capable of being incorporated into the backbone of a nucleic acid or nucleic acid analogue and they comprise an intercalator comprising a flat conjugated system capable of co-stacking with nucleobases of DNA. The invention also relates to oligonucleotides or oligonucleotide analogues comprising at least one intercalator pseudo nucleotide. The invention furthermore relates to methods of synthesising intercalator pseudo nucleotides and methods of synthesising oligonucleotides or oligonucleotide analogues comprising at least one intercalator pseudonucleotide. In addition, the invention describes methods of separating sequence specific DNA(s) from a mixture comprising nucleic acids, methods of detecting a sequence specific DNA (target DNA) in a mixture comprising nucleic acids and/or nucleic acid analogues and methods of detecting a sequence specific RNA in a mixture comprising nucleic acids and/or nucleic acid analogues. In particular said methods may involve the use of oligonucleotides comprising intercalator pseudo nucleotides. The invention furthermore relates to pairs of oligonucleotides or oligonucleotide analogues capable of hybridising to one another, wherein said pairs comprise at least one intercalator pseudonucleotide. Methods for inhibiting a DNAse and/or a RNAse and methods of modulating transcription of one or more specific genes are also described.

  本发明涉及插入剂伪核苷酸。本发明的插入剂伪核苷酸能够被合并到核酸或核酸类似物的骨架中，并且它们包括一个插入剂，该插入剂包含一个平面共轭系统，能够与DNA的碱基共堆叠。本发明还涉及至少包括一个插入剂伪核苷酸的寡核苷酸或寡核苷酸类似物。此外，本发明还涉及合成插入剂伪核苷酸的方法以及合成至少包括一个插入剂伪核苷酸的寡核苷酸或寡核苷酸类似物的方法。此外，本发明还描述了从包括核酸的混合物中分离序列特异性DNA的方法，检测包括核酸和/或核酸类似物的混合物中的序列特异性DNA（目标DNA）的方法，以及检测包括核酸和/或核酸类似物的混合物中的序列特异性RNA的方法。特别是所述方法可能涉及使用包括插入剂伪核苷酸的寡核苷酸。本发明还涉及能够杂交到一起的寡核苷酸或寡核苷酸类似物的配对，其中所述配对包括至少一个插入剂伪核苷酸。还描述了抑制DNA酶和/或RNA酶的方法以及调节一个或多个特定基因的转录的方法。
• Methods and materials for detection of mutations
  申请人：PentaBase ApS

  公开号：US10988810B2

  公开（公告）日：2021-04-27

  Provided herein are specially modified blocking nucleotides allowing for the sensitive detection of low copies of variant sequences, while significantly reducing signals from non-variant sequences that are similar but not identical to the variant sequence. These nucleotides can be used to detect rare variants in a sample mixture, as described in the present methods.

  本文提供的是经过特殊修饰的阻遏核苷酸，可以灵敏地检测低拷贝的变异序列，同时显著降低与变异序列相似但不相同的非变异序列的信号。如本方法所述，这些核苷酸可用于检测样本混合物中的稀有变异体。